LE'KEISHA RODRIGUEZ: Open Payments
NPI 1710233309 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 53 payments from 15 companies in 2025. Trend: 2023 $1,397 · 2024 $1,110 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $216 |
| Novo Nordisk Inc | 10 | $167 |
| PFIZER INC. | 9 | $141 |
| GlaxoSmithKline, LLC. | 7 | $125 |
| Lilly USA, LLC | 2 | $43 |
| ABBVIE INC. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Corcept Therapeutics | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
Products named: AIRSUPRA, Wegovy, NURTEC ODT, TRELEGY ELLIPTA, FARXIGA, SHINGRIX, JARDIANCE, Rybelsus.
Industry payments across GA — which companies pay providers there.
